Vertex Draws Collaboration Interest For Hepatitis C Combo

Vertex Pharmaceuticals Inc., maker of the hepatitis C drug Incivek, has received interest from other companies to collaborate on tests of one of its experimental medicines for the liver disease, Chief Executive Officer Jeffrey Leiden said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.